Historical context:
The breast cancer was first noted by the Ancient Egyptians were the first to note the disease more than 3,500 years ago. One of the descriptions refers to bulging tumors of the breast that has no cure according to Edwin Smith and George Ebers papyri. ”
In 1895, Scottish surgeon George Beatson discovered that removing the ovaries from one of his patients shrank her breast tumor. But it wasn’t until 1952 Charles Huggins began removing a woman’s adrenal gland in an effort to starve the tumor of estrogen. Since than we have be discovery how breast cancer grows.
The social determinants of breast cancer likely contribute significantly to the development and mortality of the disease. These involuntary factors are shown to be of greater impact on women of color and low-income women. Low-income women are also less likely to have access to healthy foods and quality healthcare. Breast cancer influence economic by the increase is being driven by a number of factors including technological innovation, rising costs of medical and hospital care and expensive therapeutics.
The breast cancer was first noted by the Ancient Egyptians were the first to note the disease more than 3,500 years ago. One of the descriptions refers to bulging tumors of the breast that has no cure according to Edwin Smith and George Ebers papyri. ”
In 1895, Scottish surgeon George Beatson discovered that removing the ovaries from one of his patients shrank her breast tumor. But it wasn’t until 1952 Charles Huggins began removing a woman’s adrenal gland in an effort to starve the tumor of estrogen. Since than we have be discovery how breast cancer grows.
The social determinants of breast cancer likely contribute significantly to the development and mortality of the disease. These involuntary factors are shown to be of greater impact on women of color and low-income women. Low-income women are also less likely to have access to healthy foods and quality healthcare. Breast cancer influence economic by the increase is being driven by a number of factors including technological innovation, rising costs of medical and hospital care and expensive therapeutics.